Announcements
Trials
Browse
Landscape
Clinical Trials
2 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
patritumab deruxtecan
×
30 days
×
Clear all
Filters
3
NCT06469944
2026-04-13
MK-3475-06C
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
160 enrolled
NCT06445972
2026-04-02
MK-3475-06D
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
210 enrolled